IBC Oxford University Oral Abstract 37 - One anastomosis gastric bypass <i>versus</i> Roux-en-Y gastric bypass for obesity: an updated meta-analysis and systematic review of randomized controlled trials

Abstract Introduction Roux-en-Y gastric bypass (RYGB) is currently regarded as the predominant method for bariatric surgery. However, one anastomosis gastric bypass (OAGB) emerged after RYGB as a more straightforward and readily reversible operation. In this systematic review and meta-analysis, our aim is to compare both procedures and update the currently existing evidence. Methods We systematically searched PubMed, Scopus, and the Cochrane Central Register systematically searched for randomized controlled trials (RCTs) that compared OAGB with RYGB as primary operations in terms of weight loss, comorbidities resolution, and post-operative complications in bariatric patients. Revisional surgeries were excluded from the analysis. Results Twelve studies were included in this meta-analysis, with a total of 904 patients. 445 patients were assigned to OAGB group (0.49%). The follow-up periods ranged from 6 months to 60 months. Total weight loss percentage (TWL%) was statistically higher in OAGB group at 6 months (95% c.i.:0.80 to 2.94; P = 0.006) with no differences at 12, 24, 36 months when compared to RYGB. On the other hand, OAGB exhibited a significantly higher excess weight loss percentage (EWL%) in comparison to RYGB at 12 months (95% c.i.: 3.08 to 9.73; P = 0.0002). EWL% was comparable in both procedures at 6, 24, 60 months of follow-up, which suggests that OAGB yields similar weight loss outcomes when compared to RYGB. There were no statistically significant differences in terms of resolution of diabetes mellitus, hypertension, dyslipidemia, obstructive sleep apnea and musculoskeletal pain. De Novo gastro-esophageal reflux disease (GERD) (RR 2.58; 95% c.i. 1.55 to 4.3; P = 0.0003) and marginal ulcers (RR 2.7; c.i. 95% 1.07 to 6.84; P = 0.04) were significantly higher in patients who underwent OAGB in comparison to RYGB. In contrast, diarrhea and dumping syndrome had a similar incidence in both procedures. Conclusion In conclusion, OAGB is not inferior to RYGB in terms of weight loss parameters and comorbidities resolution. However, OAGB can lead to a higher risk of development of marginal ulcers and de Novo GERD.

Authors

Publication Details

Journal
British journal of surgery
Published
2025-02-01
DOI
https://doi.org/10.1093/bjs/znaf036.037
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IBC Oxford University Oral Abstract 37 - One anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity: an updated meta-analysis and systematic review of randomized controlled trials

Wah Yang, Stefan Simeonovski, Ali Aljaafreh, Abdulla Almubarak et al.
British journal of surgery
Bariatric Surgery and Outcomes
article

IBC Oxford University Oral Abstract 37 - One anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity: an updated meta-analysis and systematic review of randomized controlled trials

Wah Yang, Stefan Simeonovski, Ali Aljaafreh, Abdulla Almubarak, Yusuf Ahmed, Mohammad Ali, Isa Almubarak, Khalid M. Ataya, W Yusuf
article en

Abstract

Abstract Introduction Roux-en-Y gastric bypass (RYGB) is currently regarded as the predominant method for bariatric surgery. However, one anastomosis gastric bypass (OAGB) emerged after RYGB as a more straightforward and readily reversible operation. In this systematic review and meta-analysis, our aim is to compare both procedures and update the currently existing evidence. Methods We systematically searched PubMed, Scopus, and the Cochrane Central Register systematically searched for randomized controlled trials (RCTs) that compared OAGB with RYGB as primary operations in terms of weight loss, comorbidities resolution, and post-operative complications in bariatric patients. Revisional surgeries were excluded from the analysis. Results Twelve studies were included in this meta-analysis, with a total of 904 patients. 445 patients were assigned to OAGB group (0.49%). The follow-up periods ranged from 6 months to 60 months. Total weight loss percentage (TWL%) was statistically higher in OAGB group at 6 months (95% c.i.:0.80 to 2.94; P = 0.006) with no differences at 12, 24, 36 months when compared to RYGB. On the other hand, OAGB exhibited a significantly higher excess weight loss percentage (EWL%) in comparison to RYGB at 12 months (95% c.i.: 3.08 to 9.73; P = 0.0002). EWL% was comparable in both procedures at 6, 24, 60 months of follow-up, which suggests that OAGB yields similar weight loss outcomes when compared to RYGB. There were no statistically significant differences in terms of resolution of diabetes mellitus, hypertension, dyslipidemia, obstructive sleep apnea and musculoskeletal pain. De Novo gastro-esophageal reflux disease (GERD) (RR 2.58; 95% c.i. 1.55 to 4.3; P = 0.0003) and marginal ulcers (RR 2.7; c.i. 95% 1.07 to 6.84; P = 0.04) were significantly higher in patients who underwent OAGB in comparison to RYGB. In contrast, diarrhea and dumping syndrome had a similar incidence in both procedures. Conclusion In conclusion, OAGB is not inferior to RYGB in terms of weight loss parameters and comorbidities resolution. However, OAGB can lead to a higher risk of development of marginal ulcers and de Novo GERD.

British journal of surgeryVol. 112(Supplement_5)
Openalex Percentile: Top 94%
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.